Can You Have Prostate Cancer Without Symptoms?

Can you have prostate cancer without any symptoms?

Yes. Early prostate cancer usually causes no symptoms, according to the American Cancer Society. That creates an important distinction: symptoms are not a dependable early warning system, and their absence does not establish that cancer is absent.

When symptoms do occur, they can include a weak or slow urinary stream, urinating more often—especially at night—and blood in urine or semen. Those signs do not point to cancer by themselves. The American Cancer Society says most urinary symptoms are more likely to have another cause, and difficulty urinating is much more often due to benign prostatic hyperplasia (BPH), or noncancerous prostate enlargement.

Screening is a separate question from symptom evaluation. A PSA test measures prostate-specific antigen in the blood, but PSA can rise for reasons besides cancer, including BPH and prostatitis. The National Cancer Institute puts it plainly: “There is no specific PSA level that means that someone has prostate cancer.” A high result is a signal to interpret in context, not a diagnosis.

Are frequent nighttime urination and a weak stream signs of prostate cancer?

They can occur with prostate cancer, but these urinary changes more often have a noncancerous explanation. BPH can cause frequent nighttime urination, urgency, straining, and a weak or slow stream; it is not cancer and does not increase prostate cancer risk, according to the National Cancer Institute.

Other conditions can also affect PSA or urinary symptoms. The National Cancer Institute notes that urinary tract infections and prostate irritation, as well as benign prostate conditions, can raise PSA. That is why a symptom or a test result needs an evaluation rather than a quick conclusion.

A clinician may assess prostate symptoms with a physical exam, PSA blood test, urinalysis, and other tests based on the symptoms. If a PSA result is elevated, the National Cancer Institute says it may be repeated after 6–8 weeks before further evaluation; additional steps could include other tests, imaging, or biopsy. The point is to establish what is driving the finding before labeling it.

For a visit, describe the change clearly: “I’m urinating more often at night and my stream has weakened. What could be causing it, and what evaluation makes sense?” Include when the change began and any other urinary symptoms you have noticed. That gives the clinician a concrete starting point without assuming the cause.

Does blood in semen mean prostate cancer?

No. Blood in semen is not usually caused by something serious, and prostate cancer is a rare cause, but it should still be checked. The NHS lists possible causes such as urinary or sexually transmitted infections, recent procedures, prostatitis, and an enlarged prostate.

Blood in urine also has more than one possible explanation; BPH can cause it, according to the National Cancer Institute. Neither blood in semen nor blood in urine identifies the cause on its own. A clinician can check for common causes and arrange further tests or referral if needed.

Use a direct opening: “I noticed blood in my semen” or “I noticed blood in my urine.” Mention when it happened and whether you have other changes, such as urinary symptoms. The useful next step is an assessment that looks for the cause, not trying to diagnose cancer from one sign.

When should you discuss PSA screening?

Timing depends on risk and on the screening guidance being used, so there is no single starting age that fits every man. The National Cancer Institute says some organizations recommend discussing PSA testing at age 40 or 45 for higher-risk men, including Black men, men with BRCA variants, and men with a father or brother who had prostate cancer. The U.S. Preventive Services Task Force describes an individual decision for ages 55–69 and recommends against routine screening at age 70 or older.

The American Cancer Society gives a different set of discussion ages: age 50 for average-risk men expected to live at least 10 more years; age 45 for men at high risk, including men of African ancestry and men with a father or brother diagnosed before age 65; and age 40 for men at even higher risk, including those with multiple close relatives diagnosed before 65 or BRCA mutations. These differences make a personal discussion more useful than treating any one age as an automatic rule.

Ask about both possible benefit and possible harm. The American Cancer Society says the screening decision should be made after getting information about the potential risks and benefits. If screening is chosen, it uses a PSA blood test, and testing frequency depends on PSA level, health, family history, and preferences.

PSA results also have limits. The National Cancer Institute reports that about 6%–7% of men have a false-positive result in a given screening round, and about 25% of men biopsied after an elevated PSA are found to have prostate cancer. Those figures explain why an elevated result can lead to more assessment without proving cancer is present.

For a focused conversation, try: “Given my age, family history, and health, what are the benefits and downsides of PSA screening for me?” Then ask what follow-up would look like if the result were elevated. This keeps the decision anchored to your risk and preferences instead of treating a blood test as a yes-or-no answer.